Company Filing History:
Years Active: 2013
Title: Zoe Alicia Harrison: Innovator in Kinase Inhibition
Introduction
Zoe Alicia Harrison is a prominent inventor based in Stevenage, GB. She has made significant contributions to the field of biochemistry, particularly in the development of novel compounds that serve as inhibitors of kinase activity. Her work is crucial in advancing therapeutic options for various diseases.
Latest Patents
Zoe holds a patent for "4-oxadiazol-2-YL-indazoles as inhibitors of P13 kinases." This invention is directed to certain novel compounds, specifically compounds of formula (I) and their salts. The compounds developed by Zoe are designed to inhibit kinase activity, with a particular focus on PI3-kinase activity. She has 1 patent to her name, showcasing her innovative approach in this specialized area.
Career Highlights
Zoe Alicia Harrison is associated with GlaxoSmithKline Intellectual Property Development Limited, where she applies her expertise in the pharmaceutical industry. Her role involves researching and developing new compounds that can lead to breakthroughs in medical treatments.
Collaborations
Zoe has collaborated with notable colleagues, including Julie Nicole Hamblin and Paul Spencer Jones. These partnerships have enhanced her research efforts and contributed to the success of her projects.
Conclusion
Zoe Alicia Harrison is a dedicated inventor whose work in kinase inhibition is paving the way for new therapeutic advancements. Her contributions to the field are invaluable, and her innovative spirit continues to inspire others in the scientific community.